Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. ACN
5. IBM
6. META
7. SPY
8. NVDA
9. PRIM
10. PFE

Go back to Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results

Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 8c

November 7, 2018 7:18 AM EST

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q3 EPS of ($0.76), $0.08 better than the analyst estimate of ($0.84).

This is a very exciting time for our company, said Dr. Sharon Mates, Chairman and CEO of ITCI. We are pleased with the progress we have made in numerous... More